Evaluation of quality of clinical management of neuroendocrine tumors
Background Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence‐based standardized care for this heterogenous group remains chal...
Uloženo v:
| Vydáno v: | Cancer innovation (Print) Ročník 1; číslo 4; s. 305 - 315 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
John Wiley & Sons, Inc
01.12.2022
John Wiley and Sons Inc Wiley |
| Témata: | |
| ISSN: | 2770-9183, 2770-9191, 2770-9183 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence‐based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature.
Methods
Our study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost‐Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow‐up until June 2016 (median follow‐up: 33.6 months).
Results
Fifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy‐four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs.
Conclusion
Overall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care.
Overall, the epidemiological results of our neuroendocrine tumor (NET) cohort were comparable with findings in literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. Discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. |
|---|---|
| AbstractList | Background Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence‐based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature. Methods Our study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost‐Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow‐up until June 2016 (median follow‐up: 33.6 months). Results Fifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy‐four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs. Conclusion Overall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence-based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature.BackgroundNeuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence-based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature.Our study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost-Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow-up until June 2016 (median follow-up: 33.6 months).MethodsOur study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost-Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow-up until June 2016 (median follow-up: 33.6 months).Fifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy-four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs.ResultsFifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy-four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs.Overall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care.ConclusionOverall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. Overall, the epidemiological results of our neuroendocrine tumor (NET) cohort were comparable with findings in literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. Discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. Abstract Background Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence‐based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature. Methods Our study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost‐Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow‐up until June 2016 (median follow‐up: 33.6 months). Results Fifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy‐four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs. Conclusion Overall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence-based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature. Our study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost-Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow-up until June 2016 (median follow-up: 33.6 months). Fifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy-four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs. Overall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. Background Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and bronchopulmonary tractus. Despite a rising incidence, implementation of evidence‐based standardized care for this heterogenous group remains challenging. The European Neuroendocrine Tumor Society regularly reviews guidelines regarding diagnostic and treatment strategies for NETs. The aim of this study is to shed light on the care of patients with a NET in Belgian Limburg, to provide data as a basis for future studies and to check whether data and results are according to consensus guidelines and outcomes described in literature. Methods Our study concerned a detailed observational data collection of two large Belgian hospitals (Jessa Hospital Hasselt and Hospital Oost‐Limburg Genk) with special interest in patient profile, quality of pathology reports, use of diagnostic imaging, and overall survival. Data on 188 patients were assembled between January 2010 and December 2014 with follow‐up until June 2016 (median follow‐up: 33.6 months). Results Fifty percent of patients were male. NETs were located mainly in the digestive tract (63.8%) and lung (20.2%). Appendiceal NETs were diagnosed at a significantly younger age than other tumors (41.3 vs. 64.0 years). Overall, a mean pathology report quality score of 3.0/5 was observed with the highest scores for small bowel NETs. Diagnostic and nuclear imaging was performed in 74.5% and 29.8% of cases, respectively. Seventy‐four percent of the population survived until the end of the observation period with highest survival rates for appendiceal and small bowel NETs. Conclusion Overall, epidemiological results were comparable with findings in the literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. However, consensus with regard to bronchopulmonary NETs is still scarce and remains an objective for future research. Moreover, discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. Overall, the epidemiological results of our neuroendocrine tumor (NET) cohort were comparable with findings in literature. Gastrointestinal NETs met most of the requirements of qualitative pathology reporting and diagnostic imaging as listed in the European Neuroendocrine Tumor Society consensus guidelines. Discussing treatment strategies in specialized multidisciplinary tumor boards would facilitate regional care. |
| Author | Van der Speeten, Kurt Ivanova, Anna Sergeant, Gregory Bloemen, Hannah Mebis, Jeroen Deraedt, Karen Kneepkens, Kristien |
| AuthorAffiliation | 3 Department of Abdominal Surgery and Department Jessa & Science Jessa Hospital Hasselt Belgium 1 Department of Medicine, Faculty of Medicine and Life Sciences (LCRC) Hasselt University Diepenbeek Belgium 5 Department of Surgical Oncology and Department Future Health Ziekenhuis Oost‐Limburg Genk Belgium 2 Department of Pathology and Department Future Health Ziekenhuis Oost‐Limburg Genk Belgium 4 Department of Medical Oncology and Department Jessa & Science Jessa Hospital Hasselt Belgium |
| AuthorAffiliation_xml | – name: 1 Department of Medicine, Faculty of Medicine and Life Sciences (LCRC) Hasselt University Diepenbeek Belgium – name: 3 Department of Abdominal Surgery and Department Jessa & Science Jessa Hospital Hasselt Belgium – name: 5 Department of Surgical Oncology and Department Future Health Ziekenhuis Oost‐Limburg Genk Belgium – name: 4 Department of Medical Oncology and Department Jessa & Science Jessa Hospital Hasselt Belgium – name: 2 Department of Pathology and Department Future Health Ziekenhuis Oost‐Limburg Genk Belgium |
| Author_xml | – sequence: 1 givenname: Hannah orcidid: 0000-0002-4326-8854 surname: Bloemen fullname: Bloemen, Hannah organization: Hasselt University – sequence: 2 givenname: Kristien surname: Kneepkens fullname: Kneepkens, Kristien organization: Hasselt University – sequence: 3 givenname: Karen surname: Deraedt fullname: Deraedt, Karen organization: Ziekenhuis Oost‐Limburg – sequence: 4 givenname: Anna surname: Ivanova fullname: Ivanova, Anna organization: Hasselt University – sequence: 5 givenname: Gregory surname: Sergeant fullname: Sergeant, Gregory organization: Jessa Hospital – sequence: 6 givenname: Jeroen surname: Mebis fullname: Mebis, Jeroen organization: Jessa Hospital – sequence: 7 givenname: Kurt surname: Van der Speeten fullname: Van der Speeten, Kurt email: Kurt.Vanderspeeten@zol.be organization: Ziekenhuis Oost‐Limburg |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38089084$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kl9rFDEUxYNUbK3FbyALPijI1PydJE-lLKsuFHzR55DJ3KxZMkmbmanstzfbraUt-pTLzY_DOffe1-go5QQIvSX4nGBMPzsb6DknL9AJlRI3mih29Kg-RmfjuMWV1IQoJV-hY6aw0ljxE7Ra3do42ynktMh-cTPbGKbdvnQxpOBsXAw22Q0MkKZ9O8FcMqQ-uxISLKZ5yGV8g156G0c4u39P0c8vqx_Lb83V96_r5eVV4wTGpPFcei4w10zb6qBvGSYd055qX-20gvCedNi7nnFvQXVESs17LKnnVEAr2SlaH3T7bLfmuoTBlp3JNpi7Ri4bY8sUXASjgGgCXQtUCK4k64RSPRNOyJ5RzEjVujhoXc_dAL2r-YqNT0Sf_qTwy2zyrSG4VS2Rqip8vFco-WaGcTJDGB3EaBPkeTRU15HLmlZU9P0zdJvnkuqsDMN1E0rKtq3Uu8eWHrz8XVcFPhwAV_I4FvAPCMFmfwtmfwuG79M1z0gXprs11ywh_oP_dOB_hwi7_8ma5eWaVvoPFjvA6A |
| CitedBy_id | crossref_primary_10_5306_wjco_v16_i4_102565 |
| Cites_doi | 10.1201/b11826 10.1016/j.neo.2017.09.002 10.1093/annonc/mdq022 10.1002/cncr.25855 10.1159/000443165 10.1177/145749690609500305 10.1016/j.clcc.2017.03.020 10.1159/000457956 10.1159/000335594 10.1002/9780470316696 10.1159/000335587 10.1007/s00428-006-0250-1 10.2471/BLT.07.045120 10.32074/1591-951X-230 10.1159/000335629 10.1002/cncr.11105 10.1136/bmjopen-2019-031531 10.1001/jamaoncol.2017.0589 10.1002/cncr.23542 10.1159/000443168 10.3389/fendo.2020.604341 10.1159/000381716 10.1159/000335595 10.1002/9780470510445 10.1159/000335597 10.1016/j.dld.2020.09.031 10.1080/14656566.2016.1236916 10.1007/s10350-003-0038-1 10.1016/j.jtho.2018.12.005 10.1016/j.soc.2015.08.008 10.1002/ijc.30400 10.1159/000503721 10.4251/wjgo.v12.i8.893 10.1093/annonc/mdv041 10.1002/cncr.29099 10.1159/000335591 10.1007/s00428-007-0452-1 10.1200/JCO.2014.60.2532 10.1159/000443166 10.1002/9781119013563 10.1007/s12094-014-1174-x 10.21037/jgo-20-444 10.1159/000242109 10.1159/000443170 10.14694/EdBook_AM.2014.34.e461 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. published by John Wiley & Sons Ltd. on behalf of Tsinghua University Press. 2022 The Authors. Cancer Innovation published by John Wiley & Sons Ltd. on behalf of Tsinghua University Press. 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2022 The Authors. published by John Wiley & Sons Ltd. on behalf of Tsinghua University Press. – notice: 2022 The Authors. Cancer Innovation published by John Wiley & Sons Ltd. on behalf of Tsinghua University Press. – notice: 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1002/cai2.41 |
| DatabaseName | Wiley Online Library Open Access CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2770-9183 |
| EndPage | 315 |
| ExternalDocumentID | oai_doaj_org_article_8e191eb6e2554873b588d35c57d32031 PMC10686178 38089084 10_1002_cai2_41 CAI241 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: vzw Give Life A Chance funderid: UH RvB 145/22/11 – fundername: Novartis funderid: UH R‐6611 – fundername: vzw Give Life A Chance grantid: UH RvB 145/22/11 – fundername: ; grantid: UH R‐6611 |
| GroupedDBID | 0R~ 24P 7X7 8FI 8FJ ABDBF ABUWG ACCMX ADPDF AFKRA ALMA_UNASSIGNED_HOLDINGS ALUQN BENPR CCPQU EBS FYUFA GROUPED_DOAJ HMCUK OVD PIMPY RPM TEORI UKHRP AAMMB AAYXX AEFGJ AFFHD AGXDD AIDQK AIDYY CITATION PHGZM PHGZT WIN NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c5001-f47f4504939a808d6301b39f29f8906514d1b0fcd34fae8b17794d072f425e673 |
| IEDL.DBID | PIMPY |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001319067600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2770-9183 2770-9191 |
| IngestDate | Fri Oct 03 12:45:17 EDT 2025 Tue Nov 04 02:06:30 EST 2025 Fri Sep 05 08:23:38 EDT 2025 Tue Oct 07 07:29:40 EDT 2025 Wed Feb 19 02:04:41 EST 2025 Sat Nov 29 02:18:47 EST 2025 Tue Nov 18 22:13:30 EST 2025 Wed Jan 22 16:20:33 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | epidemiology pathology report overall survival guidelines Ki67 neuroendocrine tumors quality |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2022 The Authors. Cancer Innovation published by John Wiley & Sons Ltd. on behalf of Tsinghua University Press. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5001-f47f4504939a808d6301b39f29f8906514d1b0fcd34fae8b17794d072f425e673 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-4326-8854 |
| OpenAccessLink | https://www.proquest.com/publiccontent/docview/3090887766?pq-origsite=%requestingapplication% |
| PMID | 38089084 |
| PQID | 3090887766 |
| PQPubID | 6860418 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8e191eb6e2554873b588d35c57d32031 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10686178 proquest_miscellaneous_2902974935 proquest_journals_3090887766 pubmed_primary_38089084 crossref_primary_10_1002_cai2_41 crossref_citationtrail_10_1002_cai2_41 wiley_primary_10_1002_cai2_41_CAI241 |
| PublicationCentury | 2000 |
| PublicationDate | December 2022 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: December 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Beijing – name: Hoboken |
| PublicationTitle | Cancer innovation (Print) |
| PublicationTitleAlternate | Cancer Innov |
| PublicationYear | 2022 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2019; 9 2017; 3 2006; 95 2011; 117 2016; 19 2015; 102 2004; 47 2015; 33 2015; 121 2019; 14 2007 2020; 12 2020; 11 2016; 103 2002 2016; 17 2021; 52 2003; 97 2012; 95 2015; 26 2010; 21 2006; 449 2021; 113 2020; 110 2017; 16 2007; 451 2009; 90 2014; 16 2017; 19 2016; 139 2007; 85 2008; 113 2001; 57 2016; 25 2014; 34 2017; 105 e_1_2_13_25_1 e_1_2_13_48_1 e_1_2_13_24_1 e_1_2_13_49_1 e_1_2_13_27_1 e_1_2_13_46_1 e_1_2_13_26_1 e_1_2_13_47_1 e_1_2_13_21_1 e_1_2_13_44_1 e_1_2_13_23_1 e_1_2_13_42_1 e_1_2_13_22_1 e_1_2_13_43_1 e_1_2_13_9_1 e_1_2_13_40_1 e_1_2_13_8_1 e_1_2_13_41_1 e_1_2_13_7_1 e_1_2_13_6_1 Grahek D (e_1_2_13_37_1) 2001; 57 Van Buuren S (e_1_2_13_20_1) e_1_2_13_17_1 e_1_2_13_18_1 e_1_2_13_39_1 e_1_2_13_13_1 e_1_2_13_36_1 e_1_2_13_14_1 e_1_2_13_35_1 e_1_2_13_15_1 e_1_2_13_38_1 e_1_2_13_16_1 e_1_2_13_32_1 e_1_2_13_10_1 e_1_2_13_31_1 e_1_2_13_11_1 e_1_2_13_34_1 e_1_2_13_12_1 e_1_2_13_33_1 e_1_2_13_30_1 Zhang P (e_1_2_13_45_1) 2016; 19 e_1_2_13_5_1 e_1_2_13_4_1 Rubin DB (e_1_2_13_19_1) e_1_2_13_3_1 e_1_2_13_2_1 e_1_2_13_29_1 e_1_2_13_28_1 |
| References_xml | – volume: 17 start-page: 2191 issue: 16 year: 2016 end-page: 2205 article-title: Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies publication-title: Expert Opin Pharmacother – volume: 34 start-page: e461 year: 2014 end-page: 6 article-title: Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide publication-title: Am Soc Clin Oncol Educ Book – volume: 14 start-page: 377 issue: 3 year: 2019 end-page: 407 article-title: Best practices recommendations for diagnostic immunohistochemistry in lung cancer publication-title: J Thorac Oncol – volume: 16 start-page: 366 issue: 4 year: 2017 end-page: 71 article-title: Multidisciplinary clinics for colorectal cancer care reduces treatment time publication-title: Clin Colorectal Cancer – volume: 19 start-page: 991 issue: 12 year: 2017 end-page: 1002 article-title: Nothing but NET: a review of neuroendocrine tumors and carcinomas publication-title: Neoplasia – volume: 95 start-page: 98 issue: 2 year: 2012 end-page: 119 article-title: ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes publication-title: Neuroendocrinology – volume: 9 issue: 8 year: 2019 article-title: The utility of Ki‐67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta‐analysis publication-title: BMJ Open – year: 2007 – volume: 139 start-page: 2679 issue: 12 year: 2016 end-page: 86 article-title: The epidemiology of metastases in neuroendocrine tumors publication-title: Int J Cancer – volume: 3 start-page: 1335 issue: 10 year: 2017 end-page: 42 article-title: Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States publication-title: JAMA Oncol – volume: 102 start-page: 26 issue: 1–2 year: 2015 end-page: 32 article-title: Incidence of second primary malignancies in patients with neuroendocrine tumours publication-title: Neuroendocrinology – volume: 95 start-page: 120 issue: 2 year: 2012 end-page: 34 article-title: ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well‐differentiated pancreatic non‐functioning tumors publication-title: Neuroendocrinology – volume: 21 start-page: 1794 issue: 9 year: 2010 end-page: 1803 article-title: Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP‐NETs): results from The National Cancer Registry of Spain (RGETNE) publication-title: Ann Oncol – volume: 110 start-page: 444 issue: 6 year: 2020 end-page: 76 article-title: Neuroendocrine neoplasms of the small bowel and pancreas publication-title: Neuroendocrinology – volume: 95 start-page: 157 year: 2012 end-page: 76 article-title: ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary publication-title: Neuroendocrinology – volume: 12 start-page: 893 issue: 8 year: 2020 end-page: 902 article-title: Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors publication-title: World J Gastrointest Oncol – volume: 103 start-page: 119 issue: 2 year: 2016 end-page: 24 article-title: ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms publication-title: Neuroendocrinology – volume: 57 start-page: 393 issue: 6 year: 2001 end-page: 403 article-title: [Positron emission tomography (PET) with [18F]‐FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation] publication-title: Rev Pneumol Clin – volume: 26 start-page: 1604 issue: 8 year: 2015 end-page: 20 article-title: Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids publication-title: Ann Oncol – volume: 95 start-page: 135 issue: 2 year: 2012 end-page: 56 article-title: ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno‐ileum and the appendix including goblet cell carcinomas publication-title: Neuroendocrinology – volume: 52 start-page: 367 year: 2021 end-page: 74 article-title: Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: data from a retrospective multi‐centric study publication-title: Dig Liver Dis – volume: 47 start-page: 163 issue: 2 year: 2004 end-page: 9 article-title: Neuroendocrine carcinomas of the colon and rectum publication-title: Dis Colon Rectum – volume: 19 start-page: 1205 issue: 11 year: 2016 end-page: 10 article-title: Implementation of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm publication-title: Zhonghua Wei Chang Wai Ke Za Zhi – volume: 95 start-page: 88 issue: 2 year: 2012 end-page: 97 article-title: ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms publication-title: Neuroendocrinology – year: 2002 – volume: 11 year: 2020 article-title: Clinical epigenetics of neuroendocrine tumors: the road ahead publication-title: Front Endocrinol – volume: 90 start-page: 349 issue: 4 year: 2009 end-page: 63 article-title: The German NET‐registry: an audit on the diagnosis and therapy of neuroendocrine tumors publication-title: Neuroendocrinology – volume: 97 start-page: 934 issue: 4 year: 2003 end-page: 59 article-title: A 5‐decade analysis of 13,715 carcinoid tumors publication-title: Cancer – volume: 95 start-page: 74 issue: 2 year: 2012 end-page: 87 article-title: ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms publication-title: Neuroendocrinology – volume: 16 start-page: 921 issue: 10 year: 2014 end-page: 6 article-title: Second primary malignancies in patients with neuroendocrine tumors publication-title: Clin Transl Oncol – volume: 11 start-page: 1146 issue: 6 year: 2020 end-page: 54 article-title: Deaths of colon neuroendocrine tumors are associated with increasing metastatic lymph nodes and lymph node ratio publication-title: J Gastrointest Oncol – volume: 85 start-page: 867 year: 2007 end-page: 72 article-title: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Bull World Health Organ – volume: 117 start-page: 3332 issue: 15 year: 2011 end-page: 41 article-title: Neuroendocrine tumors of midgut and hindgut origin: tumor‐node‐metastasis classification determines clinical outcome publication-title: Cancer – volume: 121 start-page: 589 issue: 4 year: 2015 end-page: 97 article-title: Exploring the rising incidence of neuroendocrine tumors: a population‐based analysis of epidemiology, metastatic presentation, and outcomes publication-title: Cancer – volume: 33 start-page: 1855 issue: 16 year: 2015 end-page: 63 article-title: Carcinoid and neuroendocrine tumors: building on success publication-title: J Clin Oncol – volume: 25 start-page: 171 issue: 1 year: 2016 end-page: 94 article-title: Biochemical diagnosis and preoperative imaging of GEP NETs publication-title: Surg Oncol Clin N Am – volume: 113 start-page: 5 issue: 1 year: 2008 end-page: 21 article-title: Bronchopulmonary neuroendocrine tumors publication-title: Cancer – volume: 449 start-page: 395 issue: 4 year: 2006 end-page: 401 article-title: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system publication-title: Virchows Arch – volume: 95 start-page: 158 issue: 3 year: 2006 end-page: 61 article-title: Carcinoid tumours in the gastrointestinal tract–a population‐based study from Western Norway publication-title: Scand J Surg – volume: 103 start-page: 125 issue: 2 year: 2016 end-page: 38 article-title: ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum publication-title: Neuroendocrinology – volume: 103 start-page: 144 issue: 2 year: 2016 end-page: 52 article-title: ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas) publication-title: Neuroendocrinology – volume: 103 start-page: 139 issue: 2 year: 2016 end-page: 43 article-title: ENETS consensus guidelines update for colorectal neuroendocrine neoplasms publication-title: Neuroendocrinology – volume: 105 start-page: 196 issue: 3 year: 2017 end-page: 200 article-title: ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology‐diagnosis and prognostic stratification publication-title: Neuroendocrinology – volume: 113 start-page: 19 issue: 1 year: 2021 end-page: 27 article-title: Neuroendocrine neoplasms of the appendix, colon and rectum publication-title: Pathologica – volume: 451 start-page: 757 issue: 4 year: 2007 end-page: 62 article-title: TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system publication-title: Virchows Arch – volume-title: Flexible imputation of missing data ident: e_1_2_13_20_1 doi: 10.1201/b11826 – ident: e_1_2_13_22_1 doi: 10.1016/j.neo.2017.09.002 – ident: e_1_2_13_35_1 doi: 10.1093/annonc/mdq022 – ident: e_1_2_13_32_1 doi: 10.1002/cncr.25855 – ident: e_1_2_13_14_1 doi: 10.1159/000443165 – ident: e_1_2_13_24_1 doi: 10.1177/145749690609500305 – ident: e_1_2_13_43_1 doi: 10.1016/j.clcc.2017.03.020 – ident: e_1_2_13_31_1 doi: 10.1159/000457956 – ident: e_1_2_13_7_1 doi: 10.1159/000335594 – volume-title: Multiple imputation for nonresponse in surveys ident: e_1_2_13_19_1 doi: 10.1002/9780470316696 – volume: 19 start-page: 1205 issue: 11 year: 2016 ident: e_1_2_13_45_1 article-title: Implementation of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm publication-title: Zhonghua Wei Chang Wai Ke Za Zhi – ident: e_1_2_13_9_1 doi: 10.1159/000335587 – ident: e_1_2_13_16_1 doi: 10.1007/s00428-006-0250-1 – ident: e_1_2_13_5_1 doi: 10.2471/BLT.07.045120 – ident: e_1_2_13_40_1 doi: 10.32074/1591-951X-230 – ident: e_1_2_13_4_1 – ident: e_1_2_13_10_1 doi: 10.1159/000335629 – ident: e_1_2_13_48_1 doi: 10.1002/cncr.11105 – ident: e_1_2_13_34_1 doi: 10.1136/bmjopen-2019-031531 – ident: e_1_2_13_2_1 doi: 10.1001/jamaoncol.2017.0589 – ident: e_1_2_13_42_1 doi: 10.1002/cncr.23542 – ident: e_1_2_13_12_1 doi: 10.1159/000443168 – ident: e_1_2_13_47_1 doi: 10.3389/fendo.2020.604341 – ident: e_1_2_13_27_1 doi: 10.1159/000381716 – ident: e_1_2_13_6_1 doi: 10.1159/000335595 – ident: e_1_2_13_21_1 doi: 10.1002/9780470510445 – ident: e_1_2_13_11_1 doi: 10.1159/000335597 – ident: e_1_2_13_26_1 doi: 10.1016/j.dld.2020.09.031 – ident: e_1_2_13_25_1 doi: 10.1080/14656566.2016.1236916 – ident: e_1_2_13_29_1 doi: 10.1007/s10350-003-0038-1 – ident: e_1_2_13_33_1 doi: 10.1016/j.jtho.2018.12.005 – ident: e_1_2_13_38_1 doi: 10.1016/j.soc.2015.08.008 – ident: e_1_2_13_23_1 doi: 10.1002/ijc.30400 – ident: e_1_2_13_39_1 doi: 10.1159/000503721 – ident: e_1_2_13_36_1 doi: 10.4251/wjgo.v12.i8.893 – volume: 57 start-page: 393 issue: 6 year: 2001 ident: e_1_2_13_37_1 article-title: [Positron emission tomography (PET) with [18F]‐FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation] publication-title: Rev Pneumol Clin – ident: e_1_2_13_30_1 doi: 10.1093/annonc/mdv041 – ident: e_1_2_13_3_1 doi: 10.1002/cncr.29099 – ident: e_1_2_13_8_1 doi: 10.1159/000335591 – ident: e_1_2_13_17_1 doi: 10.1007/s00428-007-0452-1 – ident: e_1_2_13_46_1 doi: 10.1200/JCO.2014.60.2532 – ident: e_1_2_13_15_1 doi: 10.1159/000443166 – ident: e_1_2_13_18_1 doi: 10.1002/9781119013563 – ident: e_1_2_13_28_1 doi: 10.1007/s12094-014-1174-x – ident: e_1_2_13_41_1 doi: 10.21037/jgo-20-444 – ident: e_1_2_13_49_1 doi: 10.1159/000242109 – ident: e_1_2_13_13_1 doi: 10.1159/000443170 – ident: e_1_2_13_44_1 doi: 10.14694/EdBook_AM.2014.34.e461 |
| SSID | ssj0002911887 |
| Score | 2.2103925 |
| Snippet | Background
Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and... Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and... Background Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal and... Overall, the epidemiological results of our neuroendocrine tumor (NET) cohort were comparable with findings in literature. Gastrointestinal NETs met most of... Abstract Background Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms predominantly found in the gastrointestinal... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 305 |
| SubjectTerms | Cell adhesion & migration Colon Data collection Datasets Epidemiology guidelines Hospitals Ki67 Missing data Neuroendocrine tumors Original overall survival Pancreas Pathology pathology report Patients quality Survival analysis Variables |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEB9EFvEiu-tXd3WpIN6qbT6a9OjKk_WgeFDwFtomwQfayvsQ_O93Ju0r7-GKl721SSjp_DrNL2TmNwDHNZeIalUmSEVZIkSZJqWmA8fS53jjZOVFKDahbm70w0Nxu1Tqi2LCOnngznBn2uGOwlW5Q-6L5JpXUmvLZS2V5SwNGdQMWc_SZor-wQx9GN2ny5IlldGzuhyzU5GtLD9Bpf9f1PJ9hOQycw1Lz-VX2Oo5Y3zezfUbrLnmO2xc96fi2zAaDZLdcevjLk_yjS4XeY_x8xDlQs1BxNI1tq0p9y-ezZ_byXQH7i9Hdxd_kr48QlJLCoTyQnkhkeHzotSptjn6asULzwqvC2QWmbBZlfracuFLp0lnqhA2Vcyjn7pc8V1Yb9rG7UMslNWIjSX5QIEEqUi1l5p53DpLn3sewcnCaqbutcOphMWT6VSPmSHzGpFFEA8DXzq5jPdDfpPZh27Stw4NiLrpUTefoR7BwQI00zvd1PCUgraUyvMIjoZudBc6Aykb186nhhVUrQttJiPY6zAeZsLRivgEEYFeQX9lqqs9zfgxSHJnlGmTKR3BcfhQPnp5c3F-hZzpx_-wwU_YZJSLEWJrDmB9Npm7Q_hSv87G08mv4A9_ARNDDJ8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6hghCX8oZAQUGquIUmfsSTY6m2ggNVDyD1ZjmJDSvRBG12K_HvmXGyoauChMQtsR3Jj_mcGXvmG4DDRmpa1dplpIqKTCmXZw75wtGFkl68roOKySbM2RleXFTn11J9jfwQ84EbIyPu1wxwVw9Hv0lDG7cU7zhk_XZRSOSsDUKdz8crgkCMMT2eMCYnSKMcQ2b566Pp251_UaTs_5OeedNd8roaG_9Dp_f_YwQPYH9SPtPjUVoewi3fPYK7n6br9cewWMzc32kf0jHg8ic_bgMo08vZXYaLIxum79q-4SDCdL257FfDE_hyuvh88iGb8ixkjWaPqqBMUJpMBVk5zLEtCfS1rIKoAlakohSqLeo8NK1UwXlkwqpKtbkRgQDvSyOfwl7Xd_45pMq0SIvcMg-hIk2ryjFoFIFscB3KIBN4u51x20wk5JwL47sd6ZOF5UmxqkggnRv-GHk3bjZ5z0s2VzNRdizoV1_thDuLngxSX5eeTCeyzWStEVupG21aKWhDS-Bgu-B2Qu9gZc7eX8aUZQJv5mrCHV-muM73m8GKitN-0ZzpBJ6N8jH3hMSRJg5VArgjOTtd3a3plt8it3fBITuFwQQOo-j8bfD25PgjKV8v_q3ZS7gnOGwjuuEcwN56tfGv4E5ztV4Oq9cROb8AuyQZFQ priority: 102 providerName: Wiley-Blackwell |
| Title | Evaluation of quality of clinical management of neuroendocrine tumors |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcai2.41 https://www.ncbi.nlm.nih.gov/pubmed/38089084 https://www.proquest.com/docview/3090887766 https://www.proquest.com/docview/2902974935 https://pubmed.ncbi.nlm.nih.gov/PMC10686178 https://doaj.org/article/8e191eb6e2554873b588d35c57d32031 |
| Volume | 1 |
| WOSCitedRecordID | wos001319067600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2770-9183 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002911887 issn: 2770-9183 databaseCode: DOA dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2770-9183 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002911887 issn: 2770-9183 databaseCode: BENPR dateStart: 20220601 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 2770-9183 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002911887 issn: 2770-9183 databaseCode: 7X7 dateStart: 20220601 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2770-9183 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002911887 issn: 2770-9183 databaseCode: PIMPY dateStart: 20220601 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 2770-9183 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002911887 issn: 2770-9183 databaseCode: WIN dateStart: 20220101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2770-9183 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002911887 issn: 2770-9183 databaseCode: 24P dateStart: 20220101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEB6xLUJceMMGlipIK26hiR-xc0K7q67oYasIgSinKA8bKrHJbtMi8e-ZcdJAtcCJixXHVmRnHh7bM98AHJdcIlWLPEBTlAVC5GGQa7pwzG2MFSMLK1yyCbVY6OUySfvw6LZ3q9zpRKeoO7Rn8ttGJTytmpJOzKc8JP8cpeL47dV1QDmk6K61T6hxAGMC3tIjGKfzi_TzcObCULK1y5nHlApRzpOoi6MlHNJpma_YGxHtLVAOx_9PxudNH8rfbVu3OJ3f_7_TegD3eiPVP-m46iHcMvUjuHPRX8M_htlswAj3G-t3gZk_6HEXaOlfDm419NqhZpoaB0DBhv5me9ms2yfw8Xz24exd0OdjCEpJnldWKCskbil4kutQVzEqh4InliVWJ2jKRKKKitCWFRc2N5qArRJRhYpZVAwmVvwpjOqmNofgC1VpZIaK8AoFWmQ4bSs1s7hXlza23IPXOyJkZQ9WTjkzvmUdzDLLiFqZiDzwh45XHT7HzS6nRMWhmQC13Ytm_SXr5TPTBpnBFLHBLRbu4Xghta64LKWqOEPF58HRjn5ZL-Vt9otcHrwamlE-6dIlr02zbTOWUHow_GfSg2cdywwj4fgX8QvCA73HTHtD3W-pV18dBnhEoT2R0h4cO7772-Szs5M5GmnP_z38F3CXUViHc9M5gtFmvTUv4Xb5fbNq1xM4YCLFUi2VK_UExqezRfp-4k4wJr2YYe3TfPETiv4xSQ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70egQJAKt9DEdmLngFApW3XVdsWhSHszedh0pTYpm11Q_xS_kRnnAasCtx64JXEU-fHl89ie-QZgs-AxjmqeBWiKskCILAwyRQeOmU3wxsS5FS7ZhJxM1HSaflyDH30sDLlV9pzoiLqsC9oj3-IheeRImSTvzr4GlDWKTlf7FBotLPbN-XdcsjVvxx9wfF8xtjs62tkLuqwCQRGT_5AV0ooYDWOeZipUZYIQz3lqWWpVihNyJMooD21RcmEzo0ieKRVlKJlFeJtEcvzuFbiKPC7JhUxO5bCnw5A5lMvJx6QMkUfSqI3TJZ3TrSKbsTciWpkAXZ6APxm3F300f7ed3eS3e_t_67Y7cKszs_3t9r-4C2umugfXDztHgvswGg0q535t_Ta09Jwu-1BR_3RwDKLHTvfTVNhgCpf0F8vTet48gE-X0oiHsF7VlXkMvpClQjiXpLgo0KbEbraxYjZJw9gmlnvwuh9mXXRy65T140S3QtFMEx60iDzwhxfPWoWRi6-8J5wMxSQJ7h7U8y-6YxitDMLN5InBRSKuQnkeK1XyuIhlyRlStwcbPUJ0x1ON_gUPD14OxcgwdGyUVaZeNpqllOAM-yz24FELyqEmHHsRvyA8UCtwXanqakk1O3Yq5hEFJ0VSebDpkP23xuud7TGamU_-Xf0XcGPv6PBAH4wn-0_hJqMgFed0tAHri_nSPINrxbfFrJk_d7-sD58vG-w_ASL3dzU |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6hUlVcCuXVlFKCVHELTfyInWMpu6ICVnsAqTcriW1YiSbVPir133fGyQZWBQmptyR2omQ8nz0Tz3wDcFxziaNalQmaoiwRokyTUtOGY-lzPHGy8iIUm1CTib64KKZ9VCXlwnT8EMMPN0JGmK8J4O7K-pPfrKF1OWPvKWf9oZAqI41mYjr8X2GIYh3q4zGlUsS05l3OLN190t-7sRgFzv6_GZp34yX_tGPDQjR-fJ9PeAK7vfkZn3b6sgcPXPMUdr72G-zPYDQa2L_j1sddyuUNHa5TKOPLIWCGLgc-TNfYtqY0wni5umzni-fwfTz6dvYp6SstJLWkmCovlBcSnQVelDrVNkfYV7zwrPC6QCMlEzarUl9bLnzpNFFWFcKminmEvMsVfwFbTdu4fYiFshqH2RIToUBbq0i1l5p59MKlzz2P4N1a5KbuacipGsYv0xEoM0NCMSKLIB46XnXMG3e7fKAxG5qJKjtcaOc_TI88ox26pK7KHTpP6J3xSmptuaylspzhlBbB4XrETY_fheEpxX8plecRvB2aEXm0nVI2rl0tDCuo8BfKTEbwslOQ4U04ShGfICLQG6qz8aqbLc3sZ2D3zihpJ1M6guOgO__6eHN2eo7m18H_dXsDO9OPY_PlfPL5FTxilMMRYnIOYWs5X7nXsF1fL2eL-VFA0S33NxyE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+quality+of+clinical+management+of+neuroendocrine+tumors&rft.jtitle=Cancer+innovation+%28Print%29&rft.au=Bloemen%2C+Hannah&rft.au=Kneepkens%2C+Kristien&rft.au=Deraedt%2C+Karen&rft.au=Ivanova%2C+Anna&rft.date=2022-12-01&rft.issn=2770-9183&rft.eissn=2770-9183&rft.volume=1&rft.issue=4&rft.spage=305&rft_id=info:doi/10.1002%2Fcai2.41&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2770-9183&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2770-9183&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2770-9183&client=summon |